“…21 A second study in patients with CF demonstrated absence of alterations in systemic adiponectin levels despite the presence of insulin resistance, glucose intolerance, and subclinical chronic inflammation. 22 Finally, 2 groups evaluated the effect of LPS administration in healthy volunteers and reported that, contrary to expectations, adiponectin levels were not altered, despite the anticipated induction of proinflammatory cytokines and acute-phase response. 23,24 However, lack of modulation of adiponectin levels in this setting may simply reflect the acute nature of the inflammatory response after a single administration of LPS.…”